NAPOLI, Nicola
 Distribuzione geografica
Continente #
NA - Nord America 2.517
EU - Europa 964
AS - Asia 959
SA - Sud America 329
Continente sconosciuto - Info sul continente non disponibili 82
AF - Africa 58
OC - Oceania 2
Totale 4.911
Nazione #
US - Stati Uniti d'America 2.460
SG - Singapore 381
BR - Brasile 265
CN - Cina 262
IT - Italia 254
SE - Svezia 221
RU - Federazione Russa 117
HK - Hong Kong 106
DE - Germania 78
FR - Francia 65
GB - Regno Unito 64
VN - Vietnam 60
FI - Finlandia 54
UA - Ucraina 51
AR - Argentina 30
IN - India 30
BD - Bangladesh 26
CA - Canada 22
MX - Messico 20
ZA - Sudafrica 17
ID - Indonesia 14
BE - Belgio 13
EC - Ecuador 13
IQ - Iraq 13
ET - Etiopia 11
PK - Pakistan 11
CI - Costa d'Avorio 9
ES - Italia 9
TR - Turchia 9
SA - Arabia Saudita 8
NL - Olanda 7
PL - Polonia 7
CO - Colombia 6
IE - Irlanda 6
DZ - Algeria 5
JO - Giordania 5
MA - Marocco 5
PH - Filippine 5
PY - Paraguay 5
UZ - Uzbekistan 5
VE - Venezuela 5
AL - Albania 4
DO - Repubblica Dominicana 4
EG - Egitto 4
JP - Giappone 4
AT - Austria 3
KZ - Kazakistan 3
LT - Lituania 3
MY - Malesia 3
PA - Panama 3
GE - Georgia 2
HN - Honduras 2
IL - Israele 2
KE - Kenya 2
NI - Nicaragua 2
OM - Oman 2
PS - Palestinian Territory 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BY - Bielorussia 1
CH - Svizzera 1
CL - Cile 1
CM - Camerun 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DM - Dominica 1
GA - Gabon 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
JM - Giamaica 1
MM - Myanmar 1
MN - Mongolia 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UG - Uganda 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
Totale 4.830
Città #
Ashburn 258
Fairfield 253
Chandler 214
Singapore 199
Nyköping 161
San Jose 138
Woodbridge 122
Seattle 107
Jacksonville 106
Hong Kong 105
Houston 105
Ann Arbor 99
Beijing 99
Cambridge 86
Wilmington 81
New York 69
Milan 61
Rome 41
Brooklyn 38
Dallas 35
Lawrence 34
Los Angeles 34
Roxbury 34
Council Bluffs 32
Nanjing 32
Lauterbourg 28
Santa Clara 28
Des Moines 27
Helsinki 27
Boardman 22
Ostuni 20
São Paulo 20
Bari 19
Munich 19
Princeton 18
Moscow 17
Frankfurt am Main 15
Hanoi 15
Nanchang 15
Brussels 13
Ho Chi Minh City 13
Johannesburg 13
Columbus 12
Addis Ababa 11
Atlanta 10
Chicago 10
Inglewood 10
Rio de Janeiro 10
Abidjan 9
Buffalo 9
Dong Ket 9
Jakarta 9
Baghdad 8
Brasília 8
Hanover 8
London 8
Orem 8
Shenyang 8
Jiaxing 7
Hebei 6
Montreal 6
Paris 6
Poplar 6
San Diego 6
San Francisco 6
Tianjin 6
Amman 5
Belo Horizonte 5
Denver 5
Dublin 5
Manchester 5
Porto Alegre 5
Pune 5
Querétaro 5
Riyadh 5
Tashkent 5
The Dalles 5
Warsaw 5
Zhengzhou 5
Campinas 4
Changsha 4
Dearborn 4
Dhaka 4
Falkenstein 4
Figino 4
Guangzhou 4
Noci 4
Santo André 4
Taizhou 4
Taranto 4
Tokyo 4
Turin 4
Amsterdam 3
Ankara 3
Belford Roxo 3
Campo Grande 3
Chennai 3
Curitiba 3
Córdoba 3
General Roca 3
Totale 3.209
Nome #
Hepatocellular Carcinoma: Known and Emerging Risk Factors 234
Hepatitis C virus clearance after direct-acting antivirals in cirrhotic patients by stages of liver impairment: the ITAL-C network study 233
A different perspective on sofosbuvir-ledipasvir treatment of patients with HCV genotype 1b cirrhosis: The ital-c network study 224
HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network study 206
Kikuchi-Fujimoto Disease in an Old Italian Woman: Case Report and Review of the Literature 202
A pegylated interferon alpha-2b dose-reduction in HCV 1b patients with rapid virological response does not affect sustained virological response 181
Is hepatic lipogenesis fundamental for NAFLD/NASH? A focus on the nuclear receptor coactivator PGC-1β 179
Biliary Cystadenoma in a Female Patient with HCV-Related Liver Cirrhosis: A Case Report 173
Apoptotic effects of a chimeric plant virus carrying a mimotope of the hepatitis C virus hypervariable region 1: role of caspases and endoplasmic reticulum-stress. 171
A case of sarcoidosis with isolated hepatosplenic onset and development of inflammatory bowel disease during recovery stage 168
SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience 167
Sierotipi del virus dell'epatite C e focalità tumorale in pazienti con cirrosi epatica HCV-correlata ed epatocarcinoma 163
Hepatitis A virus and non-A, non-B virus superinfections in HBsAg chronic carriers. 158
Hepatitis C virus infection in anti-HBe-positive HBsAg carriers with chronic liver disease 150
Antifibrogenic effect of IFN-alpha2b on hepatic stellate cell activation by human hepatocytes 150
Hepatocytes activate HSC via MMP-9. Role of IFN-a2b in modulating liver fibrosis in HCV patients 147
Impairment of TLR7-dependent signaling in dendritic cells from chronic hepatitis C virus (HCV)-infected non-responders to interferon/ribavirin therapy 145
Liver fibrosis score, physical frailty, and the risk of dementia in older adults: The Italian longitudinal study on aging 142
Analysis of hepatic stiffness after viral eradication in a population with chronic hepatitis C treated with DAAs 129
Tyrosine kinase inhibitors: a potential approach to the treatment of hepatocellular carcinoma 120
Manifestazioni extraepatiche multiple in una paziente con epatite cronica C trattata con interferone-alfa 118
Asymptomatic systemic sarcoidosis arising 5 years after IFN-alfa treatment for chronic hepatitis C: a new challenge for clinicians 118
Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: a multicentre independent study supported by the Italian Drug Agency 111
Angiodisplasia gastrica di grave entità in un caso di porpore di Schonlein-Henoch 110
Clinical role of serum and tissue matrix metalloprotease-9 expression in chronic HCV patients treated with pegylated IFN-alpha2b and ribavirin 106
SCCA-IC serum levels are predictive of clinical response in HCV chronic hepatitis to antiviral therapy: a multicentric prospective study. 104
Prevalence of antibodies to hepatitis c virus among family members of patients with chronic hepatis c 102
Relationship between T lymphocyte responsiveness and T-helper1/T-helper2 type cytokine release in Chronic Hepatitis C: a critical reappraisal 102
Vasculite sistemica secondaria a trattamento con alfa-interferone in un soggetto con crioglobulinemia mista di tipo II 102
Occurrence of hepatitis delta virus infection in hepatitis B virus-infected patients with different serum patterns of preS geneencoded proteins 101
Predictive value of early virological response to treatment with different interferon-based regimens plus ribavirin in patients with chronic hepatitis C 91
Ribavirin and high dose of interferon-alfa for retreatment of patients with chronic hepatitis C resistant to IFN alone 85
Relationship between HCV serotypes and tumor focality in HCV-infected cirrhotic patients with HCC 76
Neutrophil apoptotic cell death: does it contribute to the increased infectious risk in aging? 76
The use of different Peg-interferon alpha-2b regimens plus ribavirin in HCV-1b-infected patients after rapid virological response does not affect the achievement of sustained virological response 67
Totale 4.911
Categoria #
all - tutte 18.677
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.677


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022259 0 0 1 14 27 54 12 13 16 13 51 58
2022/2023568 79 80 52 52 68 75 3 61 81 5 7 5
2023/2024212 11 36 10 38 15 71 6 8 1 1 3 12
2024/2025786 21 13 61 36 28 68 145 71 28 40 104 171
2025/20261.468 208 61 108 188 186 87 148 36 132 138 56 120
2026/2027137 27 58 52 0 0 0 0 0 0 0 0 0
Totale 4.911